ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 87

Global and Country Specific Burden Of Musculoskeletal Disorders:a Report From The Global Burden Of Diseases Musculoskeletal Expert Group

Lyn March1, Damian Hoy2, Emma Smith3, Rachelle Buchbinder4, Marita Cross3, Peter Brooks5, Theo Vos2 and Anthony D. Woolf6, 1Rheumatology, Institute of Bone and Joint Research, Kolling Institute, University of Sydney, Sydney, Australia, 2School of Population Health, University of Queensland, Brisbane, Australia, 3Rheumatology, University of Sydney, Insitute of Bone and Joint Research, Royal North Shore Hospital, St Leonards NSW, Australia, 4Monash Department of Clinical Epidemiology at Cabrini Hospital, Department of Epidemiology and Preventive Medicine, Monash University, Malvern, Victoria, Australia, 5School of Population Health, Australian Health Workforce Institute, University of Melbourne, Melbourne, Australia, 6Rheumatology Dept, Royal Cornwall Hospital, Truro Cornwall, United Kingdom

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Disability and musculoskeletal disorders

  • Tweet
  • Email
  • Print
Session Information

Title: Epidemiology and Health Services I

Session Type: Abstract Submissions (ACR)

Background/Purpose:

The first Global Burden of Diseases (GBD) Study was conducted by the World Bank and WHO during the 1990’s and ranked diseases by their contribution to burden as measured by disability adjusted life years (DALYs). All MSK disorders, with 2.1% of DALYs, ranked 12th . These were considered to be underestimates. The GBD 2010 Study aimed to repeat these DALYs to look for trends in diseases from 1990 to 2010 with updated disease definitions and literature review. The MSK Expert Group (EG) aimed to identify data for OA, RA, Back Pain, Neck Pain, Gout and Other MSK.

Methods: Systematic reviews of Medline, EMBASE, CINAHL, SIGLE and WHOLIS were screened from 1980 to 2010. Data were extracted from population-based studies using a Quality Assessment tool developed by the MSK EG. These prevalence and incidence data, together with estimates of possible covariates and relative risk of mortality, were entered into the DISMOD3 software developed by the IHME. Disability weights for health states related to MSK conditions were adjusted for distribution of severity and duration and frequency of each condition to calculate years lived with disability (YLDs) for each of the MSK conditions – OA of hip or knee, RA, Low Back Pain (LBP), Neck Pain (NP), Gout and Other MSK.

Results:

Globally non-communicable chronic disorders were identified as the growing concern and of these MSK was highlighted.

In the overall global burden (DALYs) MSK disorders had increased from 4.7% in 1990 to 6.8% in 2010, and ranked 5th behind Cardiovascular (11.8%), Injuries (11.2%), All neoplasms (7.6%) and Mental and behavioural disorders (7.4%). For burden (DALYs) of specific disorders, LBP ranked 6th; NP 21st; and Other MSK 24th. In the global disability (YLD) estimates, mental and behavioural disorders combined at 22.7% ranked 1st, while combined MSK disorders at 21.3% was a close 2nd. Collectively MSK conditions affect 2,933,367,000 people, account for 166 million YLDs and represent a relative increase of 44.7% since 1990. For disease specific causes of disability (YLDs), LBP ranked 1st globally with 83.1 million; NP ranked 4th with 33.6 million; Other MSK 6th with 28.2 million; OA was 11th with 17.1 million; and RA was 6.7 million. OA was felt to be underestimated in this analysis. OA was identified as one of the most rapidly rising (64% increase) conditions with a rank of 15th in 1990 to 11thin 2010. When developed country level data are examined MSK conditions play an even greater role, for example in Australia where combined MSK conditions (15% of DALYs) were a close second only to combined Cancer (16% of DALYs) as the leading causes of disease burden, and LBP was estimated as the leading disease specific cause of total burden (DALYs). For disability in Australia MSK conditions were the leading cause with 27% of YLDs. Country level data are derived from ihme.org.

Conclusion: Data are lacking from the African nations, South America, Eastern Europe and Australasia. OA Knee is the most common MSK condition and is showing the greatest increase. Low back and neck pain account for the greatest proportion of MSK burden globally. In many countries MSK disorders are the leading cause of disability.


Disclosure:

L. March,
None;

D. Hoy,
None;

E. Smith,
None;

R. Buchbinder,
None;

M. Cross,
None;

P. Brooks,
None;

T. Vos,
None;

A. D. Woolf,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/global-and-country-specific-burden-of-musculoskeletal-disordersa-report-from-the-global-burden-of-diseases-musculoskeletal-expert-group/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology